Zhangjiang Group

Zhangjiang Group is a prominent state-owned enterprise dedicated to the development and operation of the Zhangjiang Hi-Tech Park in Shanghai, often referred to as "China's Silicon Valley" and "Zhangjiang Pharma Valley." The company serves as a critical ecosystem orchestrator for the life sciences industry, providing high-end infrastructure, specialized laboratory spaces, and comprehensive incubation services. Through its investment arms, Zhangjiang Group provides venture capital to innovative biotech and medical device startups, fostering a dense cluster of R&D activity. The park managed by the group hosts a significant percentage of China's total drug innovation, including numerous multinational R&D centers and domestic pharmaceutical leaders. Its business model integrates industrial real estate, financial services, and strategic industrial investment to drive the growth of the biopharmaceutical sector.